Genus-optimized strategy for the identification of chlamydial type III secretion substrates

Pathogens and Disease

Volumn 69, Issue 3, 2013, Pages 213-222

  Hovis, Kelley M ^a   Mojica, Sergio ^a   Mcdermott, Jason E ^b   Pedersen, Laura ^a   Simhi, Chana ^a   Rank, Roger G ^c   Myers, Garry S A ^d   Ravel, Jacques ^d   Hsia, Ru ching ^a   Bavoil, Patrik M ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Chlamydia; Effector; Type III secretion

Indexed keywords

GENOMIC DNA; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIACEAE; CHLAMYDIASIS; CHLAMYDOPHILA PSITTACI; FEMALE; GUINEA PIG; HELA CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TYPE III SECRETION SYSTEM;

CHLAMYDIA; EFFECTOR; TYPE III SECRETION;

ANIMALS; BACTERIAL SECRETION SYSTEMS; CELL MEMBRANE; CHLAMYDIA TRACHOMATIS; GENE EXPRESSION; GENE ORDER; GUINEA PIGS; MUTATION; PROTEIN TRANSPORT; PROTEOMICS; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84890854319     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12070     Document Type: Article

References (32)

1. Arnold R, Brandmaier S, Kleine F et al. (2009) Sequence-based prediction of type III secreted proteins. PLoS Pathog 5: e1000376.
2. Balin BJ, Gerard HC, Arking EJ et al. (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187: 23-42.
3. Belland RJ, Zhong G, Crane DD et al. (2003) Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. P Natl Acad Sci USA 100: 8478-8483.
4. Bergman T, Erickson K, Galyov E, Persson C & Wolf-Watz H (1994) The lcrB (yscN/U) gene cluster of I is involved in Yop secretion and shows high homology to the spa gene clusters of Shigella flexneri and Salmonella typhimurium. J Bacteriol 176: 2619-2626.
5. Byrne GI & Ojcius DM (2004) Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2: 802-808.
6. Chellas-Gery B, Linton CN & Fields KA (2007) Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Cell Microbiol 9: 2417-2430.
7. Clifton DR, Fields KA, Grieshaber SS et al. (2004) A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. P Natl Acad Sci USA 101: 10166-10171.
8. Dean P (2011) Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol Rev 35: 1100-1125.
9. Fields KA & Hackstadt T (2000) Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol 38: 1048-1060.
10. Fields KA, Mead DJ, Dooley CA & Hackstadt T (2003) Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol 48: 671-683.
11. Fields KA, Fischer ER, Mead DJ & Hackstadt T (2005) Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J Bacteriol 187: 6466-6478.
12. Gounon P (2002) Electron microscopy in cellular microbiology: ultrastructural methods for the study of cell surface antigens and pathogenic host-cell interactions. Methods in Microbiology, Vol. 31 (Sansonetti P & Zychlinsky A, eds), pp. 531-557. Academic Press, Inc., New York, NY.
13. Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA & Altman J (1993) Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 168: 1231-1235.
14. Hakansson S, Schesser K, Persson C, Galyov EE, Rosqvist R, Homble F & Wolf-Watz H (1996) The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. EMBO J 15: 5812-5823.
15. Heddema ER, Ter Sluis S, Buys JA, Vandenbroucke-Grauls CM, van Wijnen JH & Visser CE (2006) Prevalence of Chlamydophila psittaci in fecal droppings from feral pigeons in Amsterdam, The Netherlands. Appl Environ Microbiol 72: 4423-4425.
16. Hobolt-Pedersen AS, Christiansen G, Timmerman E, Gevaert K & Birkelund S (2009) Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol Med Microbiol 57: 46-58.
17. Hower S, Wolf K & Fields KA (2009) Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 72: 1423-1437.
18. Lower M & Schneider G (2009) Prediction of type III secretion signals in genomes of gram-negative bacteria. PLoS ONE 4: e5917.
19. Lugert R, Kuhns M, Polch T & Gross U (2004) Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae. Med Microbiol Immunol 193: 163-171.
20. McDermott JE, Corrigan A, Peterson E et al. (2011) Computational prediction of type III and IV secreted effectors in gram-negative bacteria. Infect Immun 79: 23-32.
21. Page AL & Parsot C (2002) Chaperones of the type III secretion pathway: jacks of all trades. Mol Microbiol 46: 1-11.
22. Pais SV, Milho C, Almeida F & Mota LJ (2013) Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis. PLoS ONE 8: e56292.
23. Pallen MJ, Beatson SA & Bailey CM (2005) Bioinformatics, genomics and evolution of non-flagellar type-III secretion systems: a Darwinian perspective. FEMS Microbiol Rev 29: 201-229.
24. Saikku P, Leinonen M, Tenkanen L et al. (1992) Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116: 273-278.
25. Samudrala R, Heffron F & McDermott JE (2009) Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog 5: e1000375.
26. Subtil A, Parsot C & Dautry-Varsat A (2001) Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol 39: 792-800.
27. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S & Dautry-Varsat A (2005) A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56: 1636-1647.
28. WHO (2011) Prevalence and incidence of selected sexually transmitted infections. Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis. Methods and results used by WHO to generate 2005 estimates. WHO, Geneva.
29. WHO (2013) WHO Initiative for Vaccine Research. WHO, http://www.who.int/vaccine_research/diseases/soa_std/en/index1.html.
30. Wimmer M, Sandmann-Strupp R, Saikku P & Haberl R (1996) Association of chlamydial infection with cerebrovascular disease. Stroke 27: 2207-2210.
31. Ying S, Pettengill M, Ojcius DM & Hacker G (2007) Host-cell survival and death during Chlamydia infection. Curr Immunol Rev 3: 31-40.
32. Zhou X, Nydam SD, Christensen JE, Konkel ME, Orfe L, Friel P & Call DR (2012) Identification of potential type III secretion proteins via heterologous expression of Vibrio parahaemolyticus DNA. Appl Environ Microbiol 78: 3492-3494.